Slate Medicines

About Slate Medicines

Slate Medicines is a biotechnology company focused on developing next generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders. The company concentrates on neuropeptide biology to address migraine-related pathways, aiming to deliver innovative interventions for patients worldwide. While details are forthcoming, the focus appears to be on translational research and therapeutic development in the headache disorder space with an emphasis on PACAP-targeted approaches.